TRIB2

Tribbles homolog 2 · Q92519 · TRIB2 on Sugi Atlas →

363 patent compounds predicted against TRIB2, 252 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL24376312 SCHEMBL24376312 0.88 1/20
SCHEMBL30293601 SCHEMBL30293601 0.68 1/20
SCHEMBL30293626 SCHEMBL30293626 0.68 1/20
SCHEMBL24376532 SCHEMBL24376532 0.66 1/20
SCHEMBL24376319 SCHEMBL24376319 0.64 1/20
SCHEMBL24376342 SCHEMBL24376342 0.64 1/20
SCHEMBL24376425 SCHEMBL24376425 0.64 1/20
SCHEMBL24376457 SCHEMBL24376457 0.64 1/20
SCHEMBL29622114 SCHEMBL29622114 0.64 1/20
SCHEMBL29622426 SCHEMBL29622426 0.64 1/20
SCHEMBL24376374 SCHEMBL24376374 0.63 1/20
SCHEMBL29622188 SCHEMBL29622188 0.63 1/20
SCHEMBL30704496 SCHEMBL30704496 0.63 1/20
SCHEMBL24376311 SCHEMBL24376311 0.63 1/20
SCHEMBL30293563 SCHEMBL30293563 0.63 1/20
SCHEMBL23559618 SCHEMBL23559618 0.63 1/20
SCHEMBL24376413 SCHEMBL24376413 0.62 1/20
SCHEMBL24376498 SCHEMBL24376498 0.62 1/20
SCHEMBL29622153 SCHEMBL29622153 0.62 1/20
SCHEMBL24376332 SCHEMBL24376332 0.62 1/20

Clinical trials — most relevant to TRIB2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes PHASE3NOT_YET_RECRUITING
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery PHASE3COMPLETED
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER PHASE2/PHASE3RECRUITING
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma PHASE1/PHASE2COMPLETED
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk PHASE2COMPLETED
MCS110 With BRAF/MEK Inhibition in Patients With Melanoma PHASE1/PHASE2COMPLETED
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas PHASE1/PHASE2COMPLETED
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans PHASE1COMPLETED
Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients PHASE1COMPLETED
Concentration and Activity of Lapatinib in Vestibular Schwannomas EARLY_PHASE1COMPLETED
Expression and Function of the Renin-Angiotensin System in the Esophagus EARLY_PHASE1COMPLETED
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Gene Expression and Inflammation in Overweight Subjects nanCOMPLETED
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib nanCOMPLETED
Gene-Specific Responses to Exercise in Discordant Twins nanCOMPLETED
Small Extracellular Vesicles and Insulin Action nanRECRUITING
Genomic Landscape of Intramedullary Astrocytoma nanUNKNOWN
for Adipose Tissue DIabetes VAriants (fATDIVA) nanCOMPLETED
The Influence of Autophagy on Fatty Liver nanUNKNOWN
Re-energize With Nutrition, Exercise and Weight Loss nanCOMPLETED
Omics-based Predictors of NAFLD/Potential NASH nanUNKNOWN
Impact Of Choline in Patients With NAFLD nanUNKNOWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED
Beige Fat, Energy, and the Natriuretic Peptide System nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise nanCOMPLETED
The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TRIB2 binder may also engage these)

ProteinNameSimilarity
Q5R669 1.000 Q5R669 →
Q5GLH2 1.000 Q5GLH2 →
Q28283 1.000 Q28283 →
Q8K4K3 1.000 Q8K4K3 →
Q7TNL3 0.991 Q7TNL3 →
Q66I46 0.990 Q66I46 →
Q7TNL4 0.990 Q7TNL4 →
Q17QV9 0.989 Q17QV9 →
Q8K4K4 0.987 Q8K4K4 →
Q8W4L3 0.987 Q8W4L3 →
Q8W490 0.987 Q8W490 →
Q9FHD7 0.987 Q9FHD7 →
Q9LET1 0.987 Q9LET1 →
Q7T0B0 0.987 Q7T0B0 →
Q6P431 0.986 Q6P431 →
Q9LX30 0.986 Q9LX30 →
Q94C95 0.986 Q94C95 →
Q62074 0.986 Q62074 →
Q9LS26 0.986 Q9LS26 →
Q5R667 0.986 Q5R667 →
Q02956 0.986 Q02956 →
F4I7Y4 0.986 F4I7Y4 →
P0DH62 0.986 P0DH62 →
PRKCZ Protein kinase C zeta type 0.985 landscape →
F1M7Y5 0.985 F1M7Y5 →
O80673 0.985 O80673 →
Q8K4K2 0.985 Q8K4K2 →
TRIB1 Tribbles homolog 1 0.985 landscape →
O22243 0.985 O22243 →
Q7T0B1 0.985 Q7T0B1 →